NeoVas Bioresorbable Coronary Scaffold Registry Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 825 participants.
Also called NCT02305472
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 825 participants
- Registry
-
NCT02305472
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT02305472. Allocation not applicable; no masking; primary purpose treatment. Start 2014-11 (registry gives no type); primary completion 2017-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- NeoVas Bioresorbable Coronary Scaffold Registry Study
- Condition
- Coronary Artery Disease
- Intervention (Device)
- NeoVas BCS
- Lead sponsor
- Lepu Medical Technology (Beijing) Co., Ltd.
Record details
- Record id
cardio:ct-nct02305472- Content hash
b7ca46cfdc5052ee501fc32f79182b50de782cc68a0c300e82c87b6a531c5083